Participation of thrombotic and haemostatic mechanisms in the initial stages of atherosclerosis;Participation des mecanismes de la thrombose et de l'hemostase aux etapes initiales de l'atherosclerose

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue SPEC. ISS. 5, 1998, Pages 41-51

  Drouet, L ^a   Mazoyer, E ^a   Bal Dit Sollier, C ^a   Hainaud, P ^a   Ripoll, L ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; LIPID; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBIN; THROMBOPLASTIN; UROKINASE; VON WILLEBRAND FACTOR;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; FIBRINOLYSIS; HEMOSTASIS; HUMAN; LIPID STORAGE; MACROPHAGE; MONOCYTE; THROMBOSIS; VASCULAR ENDOTHELIUM; ARTERIOSCLEROSIS; BLOOD; FIBRINOLYTIC THERAPY; PHYSIOLOGY; REVIEW; THROMBOCYTE AGGREGATION;

ARTERIOSCLEROSIS; FACTOR VII; HEMOSTASIS; HUMANS; MACROPHAGES; PLATELET AGGREGATION; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 0031782039     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol 1977 ; 86 : 675-84.
2. Fuster V, Badimon L, Badimon JJ, Ip JH, Chesebro JH. The porcine model for the understanding of thrombogenesis and atherogenesis. Mayo Clin Proc 1991 ; 66 : 818-31.
3. Holvoet P, Collen D. Thrombosis and Atherosclerosis. Curr Opin Lipidol 1997 ; 8 : 320-8.
4. Celermajer DS, Sorensen K, Ryalls M et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 1993 ; 22 : 854-8.
5. Zimmerman GA, McIntyre TM, Pressott SM. Adhesion and signaling in vascular cell-cell interactions. J Clin Invest 1996 ; 98 : 1699-702.
6. Poston RN, Johnson Tidey RR. Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: Implications for atherogenesis. Am J Pathol 1996 ; 149 : 73-80.
7. Mehta A, Yang B, Khan S, Hendricks JB, Stephen C, Mehta JL. Oxidized low-density lipoproteins facilitate leukocyte adhesion to aortic Intima without affecting endothelium-dependent relaxation. Role of P-selectin. Arterioscler Thromb Vasc Biol 1995 ; 15 : 2076-83.
8. Wenzel K, Ernst M, Rohde K, Baumonn G, Speer A. DNA polymorphisms in adhesion molecule genes - a new risk factor for early atherosclerosis. Hum Genet 1996 ; 97 : 15-20.
9. Haught WH, Mansour M, Rothlein R et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996 ;132:1-8.
10. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. lnterleukin-8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem 1996 ; 271 : 8837-42.
11. Wang X, Yue TL, Ohlstein EH, Sung CP, Feuerstein GZ. Interferon inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem 1996 ; 271 : 24286-93.
12. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995 ; 15 : 1145-51.
13. Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996 ; 149 : 367-80.
14. Simons LA, Sullivan D, Simons J, Celermajer DS. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. Atherosclerosis 1998 ; 137 : 197-203.
15. Gourthier TW, Scalia R, Murohara T, Guo JP, Lefer AM. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995 ; 15 : 1652-9.
16. Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 1996 ; 47 : 315-31.
17. Morrow JD, Roberts LJ. The Isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996 ; 51 : 1-9.
18. Anti Platelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. I- Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Brit Med J 1994 ; 308 : 81-106.
19. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke and venous thrombosis. Lancet 1997 ; 349 : 385-88.
20. Murata M, Matsubara Y, Kawano K et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 1997 ; 96 : 3281-6
21. Chen LY, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol 1996 ; 27 : 154-8.
22. Nichols TC, Bellinger DA, Reddick RL et al. von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stress. Arterioscler Thromb Vasc Biol. 1998 ; 18 : 323-30.
23. Lip GY, Blann AD. von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J 1995 ; 74 : 580-3.
24. Cortellaro M, Baldossarre D, Cofrancesco E et al. Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease. Stroke 1996 ; 27 : 450-4.
25. Taubman MB, Fallon JT, Schecter AD et al. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997 ; 78 : 200-4.
26. Jang Y, Guzman LA, Lincoff AM et al. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circul 1995 ; 92 : 3041-50.
27. Abumiya T, Yamaguchi T, Terasaki T, Kokawa T, Kario K, Kato H. Decreased plasma tissue factor pathway inhibitor activity in ischemic stoke patients. Thromb Haemost 1995 ; 74 : 1050-4.
28. Ko FN, Yang YC, Huang SC, Ou JT. Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J Clin Invest 1996 ; 98 : 1493-1501.
29. Schini-Kerth VB, Fisslthaler B, Andersen TT, Fenton Jwn. Vanhoutte PM, Busse R. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically activated thrombin receptor. Thromb Haemost 1995 ; 74 : 980-6.
30. Shirk RA, Church FC, Wagner WD. Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II. Arterioscler Thromb Vasc Biol. 1996 ; 16 : 1138-46.
31. Rogosta M, Barry WL, Gimple LW et al. Effect of thrombin inhibition with desultatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits. Circulation 1996 ; 93 : 1194-200.
32. Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr 1996 ; 126 : 1285 S-1289 S.
33. Smith EB, Keen GA, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis 1990 ; 10 : 263-73.
34. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh artery study. Circulation 1993 ; 87 : 1915-20.
35. de Maat MPM, Kastelein JJP, Wouter Jukema J et al. 455G/A polymorphism of the β-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men. Proposed role for an acute-phase reaction pattern of fibrinogen. Arteriocler Thromb Vasc Biol. 1998 ; 18 : 265-71.
36. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995 ; 92 : 657-71.
37. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998 ; 97 : 425-8.
38. Qing Xiao, Mary Jo S Danton, David P Witte et al. Degen fibrinogen deficiency is compatible with the development of atherosclerosis in mice. J Clin Invest 1998 ; 101 : 1184-94.
39. Schneider DJ, Ricci MA, Toatjes DJ et al. Changes in arterial expression of fibrinolytic system proteins in atherogenesis. Arterioscler Thromb Vas Biol 1997 ; 17 : 3294-302.
40. Robbie LA, Booth NA, Brown AJ, Bennett B. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol 1996 ; 16 : 539-45.
41. Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta3 binding to vitronectin. Nature 1996 ; 383 : 441-3.
42. Hajjar KA, Nachmann RL The role of lipoprotein (a) in atherogenesis and thrombosis. Annu Rev Med 1996 ; 47 : 423-42.